GLP-1 receptor agonist suppresses fatty infiltration while improving range of motion and electromyographic function in a chronic rotator cuff tear rat model | Synapse
March 3, 2026
GLP-1 receptor agonist suppresses fatty infiltration while improving range of motion and electromyographic function in a chronic rotator cuff tear rat model
Key Points
Rotator cuff tear treatment showed improved range of motion and reduced fatty infiltration.
The study reported significant enhancements in electromyographic function following GLP-1 receptor agonist treatment.
Assessment using a chronic rotator cuff tear rat model revealed promising results with ongoing therapeutic implications.
These findings suggest the potential for GLP-1 receptor agonists in rotator cuff rehabilitation, although more studies in humans are needed.